← Back to Clinical Trials
Recruiting NCT06587477

NCT06587477 Testicular Function and Semen Quality in Male Childhood and Adolescent Cancer Survivors

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06587477
Status Recruiting
Phase
Sponsor The University of Hong Kong
Condition Cancer, Treatment-Related
Study Type OBSERVATIONAL
Enrollment 200 participants
Start Date 2023-01-16
Primary Completion 2027-12-31

Eligibility & Interventions

Sex Male only
Min Age 18 Years
Max Age 50 Years
Study Type OBSERVATIONAL
Interventions
Hormonal profileSemen analysisQuestionnaire

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 200 participants in total. It began in 2023-01-16 with a primary completion date of 2027-12-31.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

Cancer treatment can affect the testicular function, including sperm and hormonal functions. The aim of this study is to assess the testicular function and semen quality in young men who recover from childhood and adolescent cancer in Hong Kong. This can provide more information for pre-treatment counselling as well as improve post treatment survivorship care. The testicular function will be compared to aged-matched controls from men attending the Family Planning Association for premarital check-up.

Eligibility Criteria

Inclusion Criteria: * Men who have received chemotherapy and/ or radiotherapy for cancer diagnosed when they were \< 18 years old. * \> 18 years old to 50 years old * Cancer in remission for at least 2 years Exclusion Criteria: * Unable to ejaculate by masturbation to provide semen samples * Cryptorchidism, testicular cancer, history of vasectomy * On testosterone replacement therapy * Refusal to join the study

Contact & Investigator

Central Contact

Jennifer Ko

✉ jenko@hku.hk

📞 22554647

Frequently Asked Questions

Who can join the NCT06587477 clinical trial?

This trial is open to male participants only, aged 18 Years or older, up to 50 Years, studying Cancer, Treatment-Related. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06587477 currently recruiting?

Yes, NCT06587477 is actively recruiting participants. Contact the research team at jenko@hku.hk for enrollment information.

Where is the NCT06587477 trial being conducted?

This trial is being conducted at Hong Kong, China.

Who is sponsoring the NCT06587477 clinical trial?

NCT06587477 is sponsored by The University of Hong Kong. The trial plans to enroll 200 participants.

Related Trials

Related Intelligence Guides

In-depth guides covering this condition's trials, eligibility, and what to expect.

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology